drugset / Trial / NCT06531369
Flumazenil Antagonism of Remimazolam in Kidney Transplant Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
To investigate the effect of different doses of flumazenil antagonism on remimazolam plasma concentration in patients undergoing renal transplantation under general anesthesia.
Timeline
- Start
- 2024-07
- Primary completion
- 2025-12
- Completion
- 2026-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Flumazenil | Small molecule | 0.3 mg | — |
| Comparator | Flumazenil | Small molecule | 0.5 mg | — |
Indications
No indication recorded.